Jefferies Group’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $3.37M | Buy |
488,580
+334,985
| +218% | +$2.33M | 0.03% | 444 |
|
|
2022
Q2 | $1.28M | Buy |
153,595
+79,150
| +106% | +$1.11M | 0.01% | 728 |
|
|
2022
Q1 | $1.7M | Sell |
74,445
-40,753
| -35% | -$996K | 0.01% | 734 |
|
|
2021
Q4 | $3.18M | Buy |
115,198
+58,448
| +103% | +$1.56M | 0.02% | 623 |
|
|
2021
Q3 | $1.58M | Buy |
56,750
+56,135
| +9,128% | +$1.59M | 0.01% | 835 |
|
|
2021
Q2 | $18K | Sell |
615
-82,620
| -99% | -$2.5M | ﹤0.01% | 1586 |
|
|
2021
Q1 | $2.64M | Buy |
83,235
+57,319
| +221% | +$1.68M | 0.02% | 584 |
|
|
2020
Q4 | $539K | Buy |
25,916
+11,243
| +77% | +$210K | ﹤0.01% | 1109 |
|
|
2020
Q3 | $228K | Buy |
14,673
+58
| +0.4% | +$999 | ﹤0.01% | 1157 |
|
|
2020
Q2 | $267 | Sell |
14,615
-23,351
| -62% | -$411K | ﹤0.01% | 1032 |
|
|
2020
Q1 | $579K | Sell |
37,966
-165,534
| -81% | -$3.99M | 0.01% | 1258 |
|
|
2019
Q4 | $6.09M | Buy |
203,500
+10,062
| +5% | +$262K | 0.05% | 433 |
|
|
2019
Q3 | $4.23M | Sell |
193,438
-27,479
| -12% | -$629K | 0.03% | 608 |
|
|
2019
Q2 | $5.57M | Buy |
220,917
+5,412
| +3% | +$128K | 0.04% | 422 |
|
|
2019
Q1 | $5.32M | Buy |
215,505
+30,305
| +16% | +$724K | 0.04% | 423 |
|
|
2018
Q4 | $3.42M | Sell |
185,200
-54,237
| -23% | -$1.29M | 0.03% | 574 |
|
|
2018
Q3 | $6.15M | Buy |
+239,437
| New | +$5.48M | 0.04% | 453 |
|
|
2018
Q2 | – | Sell |
-38,738
| Closed | -$801K | – | 2309 |
|
|
2018
Q1 | $617K | Sell |
38,738
-651,262
| -94% | -$12.1M | ﹤0.01% | 1402 |
|
|
2017
Q4 | $14.3M | Buy |
690,000
+435,855
| +171% | +$6.91M | 0.07% | 207 |
|
|
2017
Q3 | $3.64M | Sell |
254,145
-109,512
| -30% | -$1.66M | 0.02% | 657 |
|
|
2017
Q2 | $6.29M | Sell |
363,657
-4,956,873
| -93% | -$59.4M | 0.04% | 431 |
|
|
2017
Q1 | $58.7M | Buy |
5,320,530
+5,221,956
| +5,297% | +$71.8M | 0.44% | 28 |
|
|
2016
Q4 | $1.43M | Buy |
98,574
+67,177
| +214% | +$1.23M | 0.01% | 1080 |
|
|
2016
Q3 | $771K | Sell |
31,397
-31,250
| -50% | -$809K | ﹤0.01% | 1409 |
|
|
2016
Q2 | $1.26M | Buy |
62,647
+28,603
| +84% | +$810K | 0.01% | 1074 |
|
|
2016
Q1 | $895K | Sell |
34,044
-40,930
| -55% | -$3.03M | 0.01% | 1186 |
|
|
2015
Q4 | $7.62M | Buy |
74,974
+60,588
| +421% | +$6.81M | 0.04% | 334 |
|
|
2015
Q3 | $2.57M | Sell |
14,386
-5,279
| -27% | -$1.23M | 0.01% | 783 |
|
|
2015
Q2 | $4.37M | Sell |
19,665
-89,073
| -82% | -$19.7M | 0.02% | 570 |
|
|
2015
Q1 | $21.6M | Sell |
108,738
-327,799
| -75% | -$58.2M | 0.12% | 109 |
|
|
2014
Q4 | $62.5M | Buy |
436,537
+155,470
| +55% | +$20.9M | 0.37% | 54 |
|
|
2014
Q3 | $36.9M | Buy |
+281,067
| New | +$33.5M | 0.25% | 69 |
|
|
2014
Q2 | – | Sell |
-6,705
| Closed | -$855K | – | 2075 |
|
|
2014
Q1 | $884K | Buy |
+6,705
| New | +$917K | 0.01% | 983 |
|
|
2013
Q3 | – | Sell |
-10,000
| Closed | -$861K | – | 1930 |
|
|
2013
Q2 | $861K | Buy |
+10,000
| New | +$788K | 0.01% | 833 |
|
Other funds holding BHC
IC
PC
GAM
LCM
N
MP
Jefferies Group's BHC Position: Q3 2022 in Review
Jefferies Group increased its Bausch Health (BHC) stake by 218% in Q3 2022, buying an estimated $2.33M and bringing the position to 488,580 shares worth $3.37M. The position accounts for 0.03% of the portfolio, ranked #444.
Jefferies Group first reported a position in BHC in Q2 2013 and has held it in 34 quarters since. The position peaked at $62.5M in Q4 2014. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.
- Jefferies Group held 488,580 shares of Bausch Health worth $3.37M as of Q3 2022.
- Jefferies Group bought 334,985 Bausch Health shares in Q3 2022, an estimated $2.33M.
- Bausch Health made up 0.03% of Jefferies Group's portfolio in Q3 2022, its #444 holding.
- Jefferies Group first reported a position in Bausch Health in Q2 2013 and has held it in 34 quarters since.
- Jefferies Group's Bausch Health position peaked at $62.5M in Q4 2014.
- 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.